Lastest Insider Transactions Of AN2 Therapeutics, Inc. ( ANTX ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | 2024-11-18 | Buy | 50,000 | 1.00 | 49,970 | 2024-11-18 20:51:42 |
ANTX | AN2 Therapeutics, Inc. | Leonard Braden Michael | 10% Owner | 2024-08-14 | Buy | 1,500,000 | 1.04 | 1,560,000 | 2024-08-14 20:24:00 |
ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 2024-08-09 | Sell | 3,525,094 | 1.08 | 3,807,102 | 2024-08-13 17:03:34 |
ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Directior | 2024-01-18 | Sell | 100,000 | 19.11 | 1,911,410 | 2024-01-19 19:32:12 |
ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Directior | 2024-01-16 | Sell | 100,000 | 19.65 | 1,965,000 | 2024-01-18 18:19:41 |
ANTX | AN2 Therapeutics, Inc. | Adjuvant Global Health Technology Fund, L.P. | 10% Owner | 2024-01-16 | Sell | 100,000 | 19.65 | 1,965,000 | 2024-01-18 18:18:45 |
ANTX | AN2 Therapeutics, Inc. | Readnour Robin Shane | Directior | 2024-01-12 | Sell | 1,425 | 21.91 | 31,229 | 2024-01-17 17:03:32 |
ANTX | AN2 Therapeutics, Inc. | Readnour Robin Shane | Directior | 2024-01-10 | Sell | 3,669 | 21.93 | 80,443 | 2024-01-12 17:08:10 |
ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Officer | 2024-01-09 | Sell | 7,417 | 20.14 | 149,367 | 2024-01-11 19:59:41 |
ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Officer | 2024-01-09 | Option Exercise | 7,417 | 4.59 | 34,015 | 2024-01-11 19:59:41 |
ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Officer | 2024-01-02 | Sell | 2,583 | 20.12 | 51,967 | 2024-01-04 18:06:42 |
ANTX | AN2 Therapeutics, Inc. | Krause Kevin Michael | Chief Strategy Officer | 2024-01-02 | Option Exercise | 2,583 | 0.42 | 1,085 | 2024-01-04 18:06:42 |
ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | 2024-01-02 | Sell | 2,777 | 20.09 | 55,802 | 2024-01-04 18:05:51 |
ANTX | AN2 Therapeutics, Inc. | Adjuvant Global Health Technology Fund, L.P. | 10% Owner | 2023-11-14 | Sell | 1,810 | 16.15 | 29,224 | 2023-11-16 18:59:54 |
ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Directior 10% Owner | 2023-11-14 | Sell | 1,810 | 16.15 | 29,224 | 2023-11-16 18:57:17 |
ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Directior 10% Owner | 2023-09-29 | Sell | 104,773 | 16.27 | 1,704,513 | 2023-10-03 19:21:18 |
ANTX | AN2 Therapeutics, Inc. | Adjuvant Global Health Technology Fund, L.P. | 10% Owner | 2023-09-29 | Sell | 104,773 | 16.27 | 1,704,513 | 2023-10-03 19:13:42 |
ANTX | AN2 Therapeutics, Inc. | Adjuvant Global Health Technology Fund, L.P. | 10% Owner | 2023-09-27 | Sell | 9,357 | 16.11 | 150,708 | 2023-09-29 17:41:08 |
ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Directior 10% Owner | 2023-09-27 | Sell | 9,357 | 16.11 | 150,708 | 2023-09-29 17:40:05 |
ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Directior 10% Owner | 2023-08-23 | Sell | 400 | 16.00 | 6,400 | 2023-09-15 17:40:36 |
ANTX | AN2 Therapeutics, Inc. | Adjuvant Global Health Technology Fund, L.P. | 10% Owner | 2023-08-23 | Sell | 400 | 16.00 | 6,400 | 2023-09-15 17:17:35 |
ANTX | AN2 Therapeutics, Inc. | Adjuvant Global Health Technology Fund, L.P. | 10% Owner | 2023-08-23 | Sell | 7,140 | 16.03 | 114,484 | 2023-09-08 16:59:56 |
ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Directior 10% Owner | 2023-08-23 | Sell | 7,140 | 16.03 | 114,484 | 2023-09-08 16:57:59 |
ANTX | AN2 Therapeutics, Inc. | Adjuvant Global Health Technology Fund, L.P. | 10% Owner | 2023-08-23 | Sell | 400 | 16.00 | 6,400 | 2023-08-25 16:31:35 |
ANTX | AN2 Therapeutics, Inc. | Aziz Kabeer | Directior 10% Owner | 2023-08-23 | Sell | 400 | 16.00 | 6,400 | 2023-08-25 16:30:49 |
ANTX | AN2 Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 2023-08-18 | Buy | 1,777,778 | 9.00 | 16,000,002 | 2023-08-22 17:01:31 |
ANTX | AN2 Therapeutics, Inc. | Easom Eric | Chief Executive Officer | 2023-05-15 | Buy | 10,000 | 5.38 | 53,770 | 2023-05-15 20:01:16 |